British doctors called on Tuesday for Roche's cancer drug Avastin to be made routinely available as a cheap alternative for treating people with a debilitating eye disorder. Doctors from 120 Clinical Commissioning Groups said using Avastin ‘off-label’ to treat the potentially blinding condition of wet Age-related Macular Degeneration (AMD) could save the National Health Service (NHS) 102 million pounds ($158 million) a year. Avastin costs about 60 pounds when used for eye injections, far less than Lucentis, which is specifically licensed for wet AMD and is priced at about 700 pounds.
via Health News Headlines - Yahoo News http://ift.tt/1BOo2TP
No comments:
Post a Comment